Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study
Current Oncology · 2026
DOI: 10.3390/curroncol33010049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2026. Verfasst von Joshua O Cerasuolo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON L8N 3Z5, Canada. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Cancer Survivors, Radiation Oncology. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer survivors require coordinated long-term care after treatment. We examined patterns of follow-up care and identified characteristics associated with the frequency of radiation oncology (RO) visits during survivorship. We conducted a population-based cohort study of men diagnosed with prostate cancer between April 2010 and March 2019 in Ontario, Canada, who underwent first-line radiotherapy. Survivorship began three years following radiation. Using a recurrent event framework, we identified demographic and clinical characteristics associated with the rate of RO follow-up. Survivors seeking RO follow-up declined by 46.2% over five years of survivorship. Higher-risk characteristics, such as higher ISUP grade, higher stage, detectable prostate-specific antigen (PSA) score, and receipt of brachytherapy and/or hormones, were associated with more frequent RO visits. For instance, relative to International Society of Urological Pathology (ISUP) Grade 1, those with Grades 3 through 5 experienced follow-up rates that were 20%, 25%, and 34% higher, respectively. Despite concordance between patient risk and rate of RO follow-up, 23.6% of survivors continued to visit their RO providers into their fifth year of survivorship, more than half of whom were ISUP grades 1–2. Primary care follow-up remained stable. While frequency of RO follow-up appropriately reflected patient risk profile, many low-risk survivors still sought long-term RO-led care. This suggests an opportunity to encourage lower-risk prostate cancer survivors to seek follow-up care with their general practitioner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON L8N 3Z5, Canada.
- ICES McMaster, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.
- ICES North, Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada.
- Medical Sciences Division, NOSM University, Sudbury, ON P3E 2C6, Canada.
- Department of Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON L8V 5C2, Canada.
- ICES, Toronto, ON M4N 3M5, Canada.
ORCID-Profile: Jonathan Sussman, Manaf Zargoush, Hsien Seow
Zitieren
APA
Cerasuolo, J. O., Sussman, J., Dayes, I. S., Sutradhar, R., Zargoush, M., & Seow, H. (2026). Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study. Current Oncology. https://doi.org/10.3390/curroncol33010049
Vancouver
Cerasuolo JO, Sussman J, Dayes IS, Sutradhar R, Zargoush M, Seow H. Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study. Current Oncology. 2026. doi:10.3390/curroncol33010049
BibTeX
@article{Cerasuolo2026,
author = {Cerasuolo, Joshua O and Sussman, Jonathan and Dayes, Ian S and Sutradhar, Rinku and Zargoush, Manaf and Seow, Hsien},
title = {Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study},
journal = {Current Oncology},
year = {2026},
doi = {10.3390/curroncol33010049}
}
EUVIMED